Abstract

Mouse models of human disease remain the bread and butter of modern biology and therapeutic discovery. Nonetheless, more often than not mouse models do not reproduce the pathophysiology of the human conditions they are designed to mimic. Naturally occurring large animal models have predominantly been found in companion animals or livestock because of their emotional or economic value to modern society and, unlike mice, often recapitulate the human disease state. In particular, numerous models have been discovered in dogs and have a fundamental role in bridging proof of concept studies in mice to human clinical trials. The present article is a review that highlights current canine models of human diseases, including Alzheimer's disease, degenerative myelopathy, neuronal ceroid lipofuscinosis, globoid cell leukodystrophy, Duchenne muscular dystrophy, mucopolysaccharidosis, and fucosidosis. The goal of the review is to discuss canine and human neurodegenerative pathophysiologic similarities, introduce the animal models, and shed light on the ability of canine models to facilitate current and future treatment trials.

Highlights

  • The utility of canine models of neurodegenerative diseases has increased over the last decade

  • Clinical trials of novel therapeutics for Alzheimer’s disease (AD) have not been tested in Canine Cognitive Dysfunction (CCD) dogs to our knowledge, and this is likely due to the complexities associated with conducting client owned animal clinical trials and/or a lack of a comprehensive natural history study of CCD

  • Even if the pathophysiology of degenerative myelopathy (DM) mimics only a fraction of Amyotrophic lateral sclerosis (ALS) cases, DM may remain a useful animal model for ALS insofar as it could afford us insights into the interplay between the unfolded protein response (UPR) of microglia and astrocytes and the spinal cord inflammation seen in the two diseases

Read more

Summary

Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases

Gray-Edwards HL (2020) Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases. Mouse models of human disease remain the bread and butter of modern biology and therapeutic discovery. Occurring large animal models have predominantly been found in companion animals or livestock because of their emotional or economic value to modern society and, unlike mice, often recapitulate the human disease state. The present article is a review that highlights current canine models of human diseases, including Alzheimer’s disease, degenerative myelopathy, neuronal ceroid lipofuscinosis, globoid cell leukodystrophy, Duchenne muscular dystrophy, mucopolysaccharidosis, and fucosidosis. The goal of the review is to discuss canine and human neurodegenerative pathophysiologic similarities, introduce the animal models, and shed light on the ability of canine models to facilitate current and future treatment trials

INTRODUCTION
Canine Models of Neurodegenerative Diseases
Canine Cognitive Dysfunction
Therapeutic Testing in the Canine Model
Impacts on Patients With Disease
Amyotrophic Lateral Sclerosis in Humans
Degenerative Myelopathy in Canines
Impact on Patients With This Disease
Neuronal Ceroid Lipofuscinosis in Humans
Neuronal Ceroid Lipofuscinosis in Canines
Impacts on Patients With This Disease
Globoid Cell Leukodystrophy in Humans
Globoid Cell Leukodystrophy in Canines
Duchenne Muscular Dystrophy in Humans
Mucopolysaccharidosis in Humans
MPS I
MPS IIIa
MPS IIIb
MPS VII
Fucosidosis in Humans
Fucosidosis in Canines
Impacts on Patient With This Disease
SUMMARY
Findings
AUTHOR CONTRIBUTIONS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.